drug

VIR-5525

Phase 1updated 3mo ago

by $VIR Vir Biotechnology, Inc.

Phase 1

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying VIR-5525

phase1Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumorsrecruitingn=450

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

VIR-5525

Phase 1updated 3mo ago

by $VIR Vir Biotechnology, Inc.

Phase 1

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying VIR-5525

phase1Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumorsrecruitingn=450

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

VIR-5525

indications

all catalysts(0)

Trials studying VIR-5525

News(0)

Report a data issue

comments(0)

VIR-5525

indications

all catalysts(0)

Trials studying VIR-5525

News(0)

Report a data issue

comments(0)